B3-070 Congenital Disorders Flashcards

1
Q

diseases on a newborn screening have

A

significant morbidity and mortality
improved outcomes with early treatment
available testing that is simple and inexpensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

newborn screening are [sensitive/specific]

A

sensitive

confirmatory testing is always necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

newborn screenings are obtained at

A

24 hrs of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

recurrent bacterial infections means

A

4 episodes of AOM/year
2 episodes of pneumonia/year
2 episodes of sinusitis requiring antibiotics/year
recurrent abcessess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

if a recurrent infection is only occuring in one anatomic location consider

A

anatomic abnormality over immunodeficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

recurrent ear infections may be caused by

A

ET dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

recurrent UTI may be caused by

A

ureteral abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

unilobar pneumonia may be caused by

A

aspiration or anatomical anomaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

deep seated infections

A

organ abscesses
sepsis/bacteremia
fungal infections

except mucocutaneous candidiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

difficult to treat infections

A

antibiotic course greater than 2 months without improvement
need for parenteral antibiotics rather than oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

family history of primary immune deficiency triggers

A

early workup, usually prior to symptom onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

first test for possible congenital disorder

A

CBC w diff

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

lymphopenia is suggestive of

A

T cell disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

neutropenia is suggestive of

A

phagocytic disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

follow up tests should be guided by

A

clinical suspicion and family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

considerations of genetic testing

A

follow index of suspicion
sequential
consider cost
aggregate outside evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

identifies monosomy, trisomy, large deletions, translocations, non-disjunction

A

karyotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

commonly employed with multiple genetic anomalies

A

karyotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

pre natal amniotic fluid, chorionic villus tissue

A

karotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

higher resolution than chromosome analysis

A

FISH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

used fluorescent-tagged sequence/probe

A

FISH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

steps of FISH

A

denature DNA –> expose probe –> visualize under microscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

detects 50-200kb deletions

A

FISH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

limited to one disease

A

FISH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
DiGeorge is diagnosed with
FISH
26
Williams syndrome is diagnosed with
FISH
27
trisomy 21 is dx with
karyotype
28
turner syndrome is diagnosed with
karyotype
29
detects deletions >5000
karyotype
30
various mutation of gene coding regions
single gene analysis
31
Factor V Leiden is diagnosed with
single gene analysis | specific mutation
32
cystic fibrosis is diagnosed via
single gene analysis | panel of common variants
33
done by PCR
single gene analysis
34
evaluates for gains or losses of chromosome segments at much higher resolution
comparative genomic hybridization/microarray
35
can do targets vs whole genome evaluation
comparative genomic hybridization/microarray
36
in comparative genomic hybridization/microarray, patient DNA amplification is
green
37
in comparative genomic hybridization/microarray, absence of patient DNA is
red
38
in comparative genomic hybridization/microarray, equal patient and reference DNA is
yellow
39
examine multiple gene and genetic regions simultaneously
comparative genomic hybridization/microarray
40
for patients who have a likely genetic component to symptoms, but testing has not identified cause
exome sequencing/next gen sequencing
41
ideally symptom driven
exome sequencing/next gen sequencing
42
trio analysis is best for interpretation
exome sequencing/next gen sequencing
43
risks of genetic screening
can reveal non-paternity, consaguinity, unrelated parental diagnosis
44
only about 1/3 of patients will have an identified diagnosis
exome sequencing/next gen sequencing
45
the first successful HSCTs were for
SCID and WAS
46
what has contributed to a higher success rate of HSCTs?
improvements to donor selection, conditioning, and post transplant immunosuppression
47
HSCTs can serve as a "rescue" following
malignancy
48
the most important trait to qualify for HSCT
an immunodeficiency where the defect is isolated to hematopoietic cells | **not great for Hyper IgE
49
HSCT is efficacious and recommended for
SCID WAS
50
Step 1 of HSCTs
Find HLA match
51
4 types of donors
matched related donor matched unrelated donor cord blood donor mismatched related donor
52
most desirable donor
matched related | sibling
53
efficacy approaches that of matched related donors
matched unrelated donor
54
less likely to find a match for
patients of racially mixed backgrounds ethnic minorities
55
more forgiving of HLA mismatches
cord blood donor
56
requires myeloablative conditioning
cord blood donor | dangerous for patient
57
less antiviral immunity because cells are naive
cord blood match
58
takes longer for engraftment to occur
cord blood match | increased risk of infection or complication during this time
58
takes longer for engraftment to occur
cord blood match | increased risk of infection or complication during this time
59
usually haploidentical
mismatched related donor | parents
60
highest risk for graft rejection of GVHD
mismatched related donor
61
Step 2 of HSCT
Conditioning
62
may not require conditioning due to lack of immune system
SCID
63
most aggressive and reduces risk of failure of GVHD, but comes at a cost of toxicity and infections
myeloablative | need for cord blood donor
64
serves to minimize the immune response only
minimal intensity/immunosuppressive
65
generally only if you have a matched related donor
minimal intensity/immunosuppressive
66
middle ground, can be an option if patients have severe infections before transplants that would prevent myeloablative conditioning
reduced intensity
67
Step 3 HSTCs
prevent GVHD
68
the less intense conditioning regimen used,
the more immunosuppression needed after transplant to prevent GVHD
69
if myeloablative conditioning was used, the patient may become
aplastic if fails
70
donor chimerism
mixed donor and recipient cells
71
primary graft failure
never engrafted at all
72
secondary graft failure
engrafted and lost over time
73
treatment of mild GVHD
get labs and imaging go back to previous level of immunosuppression + topical corticosteroids
74
treatment of moderate to severe GVHD
labs/imaging if stable go back to previous level of immunosuppression + IV corticosteroids
75
limited area of involvement and hemodynamically stable
mild GVHD
76
IRT checks for
cystic fibrosis
77
best when there is only one specific muations you are looking for (i.e. 22q11)
FISH
78
when you need to look at very large deletions or chromosomal duplications/deletions (trisomies, monosomies)
karyotype/chromosomal analysis
79
best when there is one gene of interest, even if there are many possible mutations within that gene | CTFR
single gene analysis/PCR
80
when you are fishing for a genetic cause you believe to be syndromic
exome sequencing
81
is bronchiolitis in children reason to suspect immunodeficiency?
no
82
recurrent infections in multiple locations is concern for
immunodeficiency
83
what test should you always start with?
CBC w/ diff
84
after CBC, what test[s] are next best step in immunodeficiency workup?
**flow cytometry** Ig levels vaccine titers | results from flow cytometry can help determine need for Ig or vaccine ti
85
what genetic test should start with if uknown disorder of genetic origin is suspected?
karyotype
86
extrachromosomal DNA byproducts of T cell receptor rearrangement
TRECs
87
TRECs are only expressed in
T cells of thymic origins
88
differential for abnormal TRECs
SCID DiGeorge T cell lymphopenia Ataxia telangiectasia Wiskott Aldrich
89
SCID patients should be placed in
positive pressure rooms
90
if SCID infant requires blood products they should be
leukoreduced, irradiated, and CV negative
91
should SCID patients receive live viral vaccines?
no
92
SCID patients should receive a ........ ASAP
transplant
93
usually best match for HSCT
MDR: sibling
94
donor sources ranked best to least good
MRD>MURD>CBD>MMRD
95
how is the stem cell graft conditioned?
antibody tagged removal radiation
96
how is the recipient bone marrow conditioned?
myeloablation immunosuppression total body irradiation
97
myeloablation facilitates
engraftment
98
immunosuppression in conditioning limits
rejection
99
donor immune cells recognize recipient cells as foreign and attack
GVHD
100
acute GVHD
.<100 days after transplant
101
chronic GVHD
.>100 days after transplant
102
GVHD commonly involves what tissues?
liver, GI tract, skin,
103
short tandem repeat PCR is used to analyze
chimerism
104
HSCT only treats
immune deficiencies that arise from defects in hematopoeitic cells
105
even post HSCT, what is a common complication of WAS?
IBD
106
if GVHD is suspected and patient is stable
labs and endoscopy